Commercial Cell and Gene Therapy Revenue -- $9.1 million, up 26% year over year, reflecting growth in therapies supported.

Good day, ladies and gentlemen, and welcome to Repligen Corporation's First Quarter 2026 Earnings Conference Call. My name is Samantha, and I will be your coordinator. [Operator Instructions] I will ...

Following IDMC recommendation after interim futility analysis the decision was made to discontinue the TACTI-004 Phase III trialRoot cause ...

Focal segmental glomerulosclerosis (FSGS), a progressive kidney disease with an estimated global prevalence of 4%, occurs ...

Good morning, ladies and gentlemen. This is Marcus Poppe speaking. On behalf of Daimler Truck, I would like to welcome you to our Q1 results global conference call. We are very happy to have you with ...

Oh! How the tables have turned as Gordon Ramsay isn’t the one dishing out the critiques. One of the Michelin-starred The ...

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and combination strategy highlighted through multiple clinical ...

Distrust and misinformation have made HMOs – houses in multiple occupation – an increasingly controversial topic ...

Ahead of the election, the Southern California News Group compiled a list of questions to pose to the candidates vying to ...

The global material handling equipment market is growing steadily, expected to be valued at approximately US$ 280.5 billion in 2026 and project ...

He is the quiet man with a deep-rooted patriotism measured in substance, not flash. The Re:Build plant is massive, 1 million ...

Certain dietary patterns may reduce symptom severity by reducing inflammation and modulating hormone levels. RDs with ...